Hienrich Edi

SEC source: 0001209191-18-015302 · doc4.xml · nonDerivative · entry 17

Hienrich Edi · CIK 0001472187 · SVP/Managing Director EMEA

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,151

F6 · kind: The reporting person received 1,016 shares of common stock upon the net exercise of 5,000 SARs. The reporting person forfeited 2,760 shares of common stock underlying the SARs in payment of the exercise price and 1,224 shares of common stock underlying the SARS to satisfy the withholding tax obligations resulting from the exercise, using the closing stock price on February 27, 2018 of $86.64.

SEC source: 0001209191-18-015302 · doc4.xml · nonDerivative · entry 16

Hienrich Edi · CIK 0001472187 · SVP/Managing Director EMEA

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,911

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · kind: The reporting person received 1,016 shares of common stock upon the net exercise of 5,000 SARs. The reporting person forfeited 2,760 shares of common stock underlying the SARs in payment of the exercise price and 1,224 shares of common stock underlying the SARS to satisfy the withholding tax obligations resulting from the exercise, using the closing stock price on February 27, 2018 of $86.64.

SEC source: 0001209191-18-015302 · doc4.xml · nonDerivative · entry 15

Hienrich Edi · CIK 0001472187 · SVP/Managing Director EMEA

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,911

F5 · kind: The reporting person received 3,842 shares of common stock upon the net exercise of 13,050 SARs. The reporting person forfeited 4,586 shares of common stock underlying the SARs in payment of the exercise price and 4,622 shares of common stock underlying the SARs to satisfy the withholding tax obligations resulting from the exercise, using the closing stock price on February 27, 2018 of $86.64.

SEC source: 0001209191-18-015302 · doc4.xml · nonDerivative · entry 14

Hienrich Edi · CIK 0001472187 · SVP/Managing Director EMEA

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,533

F5 · kind: The reporting person received 3,842 shares of common stock upon the net exercise of 13,050 SARs. The reporting person forfeited 4,586 shares of common stock underlying the SARs in payment of the exercise price and 4,622 shares of common stock underlying the SARs to satisfy the withholding tax obligations resulting from the exercise, using the closing stock price on February 27, 2018 of $86.64.

SEC source: 0001209191-18-015302 · doc4.xml · nonDerivative · entry 13

Hienrich Edi · CIK 0001472187 · SVP/Managing Director EMEA

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,119

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · kind: The reporting person received 3,842 shares of common stock upon the net exercise of 13,050 SARs. The reporting person forfeited 4,586 shares of common stock underlying the SARs in payment of the exercise price and 4,622 shares of common stock underlying the SARs to satisfy the withholding tax obligations resulting from the exercise, using the closing stock price on February 27, 2018 of $86.64.

SEC source: 0001209191-18-015302 · doc4.xml · nonDerivative · entry 12

Hienrich Edi · CIK 0001472187 · SVP/Managing Director EMEA

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,069

F4 · kind: The reporting person received 1,716 shares of common stock upon the net exercise of 6,697 SARs. The reporting person forfeited 2,915 shares of common stock underlying the SARs in payment of the exercise price and 2,066 shares of common stock underlying the SARs to satisfy the withholding tax obligations resulting from the exercise, using the closing stock price on February 27, 2018 of $86.64.

SEC source: 0001209191-18-015302 · doc4.xml · nonDerivative · entry 11

Hienrich Edi · CIK 0001472187 · SVP/Managing Director EMEA

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,135

F4 · kind: The reporting person received 1,716 shares of common stock upon the net exercise of 6,697 SARs. The reporting person forfeited 2,915 shares of common stock underlying the SARs in payment of the exercise price and 2,066 shares of common stock underlying the SARs to satisfy the withholding tax obligations resulting from the exercise, using the closing stock price on February 27, 2018 of $86.64.

SEC source: 0001209191-18-015302 · doc4.xml · nonDerivative · entry 10

Hienrich Edi · CIK 0001472187 · SVP/Managing Director EMEA

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,050

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · kind: The reporting person received 1,716 shares of common stock upon the net exercise of 6,697 SARs. The reporting person forfeited 2,915 shares of common stock underlying the SARs in payment of the exercise price and 2,066 shares of common stock underlying the SARs to satisfy the withholding tax obligations resulting from the exercise, using the closing stock price on February 27, 2018 of $86.64.

SEC source: 0001209191-18-015302 · doc4.xml · nonDerivative · entry 9

Hienrich Edi · CIK 0001472187 · SVP/Managing Director EMEA

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,353

F3 · kind: The reporting person received 2,687 shares of common stock upon the net exercise of 19,245 SARs . The reporting person forfeited 13,324 shares of common stock underlying the SARs in payment of the exercise price and 3,234 shares of common stock underlying the SARs to satisfy the withholding tax obligations resulting from the exercise, using the closing stock price on February 27, 2018 of $86.64.

SEC source: 0001209191-18-015302 · doc4.xml · nonDerivative · entry 8

Hienrich Edi · CIK 0001472187 · SVP/Managing Director EMEA

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,587

F3 · kind: The reporting person received 2,687 shares of common stock upon the net exercise of 19,245 SARs . The reporting person forfeited 13,324 shares of common stock underlying the SARs in payment of the exercise price and 3,234 shares of common stock underlying the SARs to satisfy the withholding tax obligations resulting from the exercise, using the closing stock price on February 27, 2018 of $86.64.

SEC source: 0001209191-18-015302 · doc4.xml · nonDerivative · entry 7

Hienrich Edi · CIK 0001472187 · SVP/Managing Director EMEA

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,911

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · kind: The reporting person received 2,687 shares of common stock upon the net exercise of 19,245 SARs . The reporting person forfeited 13,324 shares of common stock underlying the SARs in payment of the exercise price and 3,234 shares of common stock underlying the SARs to satisfy the withholding tax obligations resulting from the exercise, using the closing stock price on February 27, 2018 of $86.64.

SEC source: 0001209191-18-015302 · doc4.xml · nonDerivative · entry 6

Hienrich Edi · CIK 0001472187 · SVP/Managing Director EMEA

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,666

F2 · kind: The reporting person received 5,392 shares of common stock upon the net exercise of 24,590 SARs. The reporting person forfeited 12,713 shares of common stock underlying the SARs in payment of the exercise price and 6,485 shares of common stock underlying the SARs to satisfy the withholding tax obligations resulting from the exercise, using the closing stock price on February 27, 2018 of $86.64.

SEC source: 0001209191-18-015302 · doc4.xml · nonDerivative · entry 5

Hienrich Edi · CIK 0001472187 · SVP/Managing Director EMEA

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,151

F2 · kind: The reporting person received 5,392 shares of common stock upon the net exercise of 24,590 SARs. The reporting person forfeited 12,713 shares of common stock underlying the SARs in payment of the exercise price and 6,485 shares of common stock underlying the SARs to satisfy the withholding tax obligations resulting from the exercise, using the closing stock price on February 27, 2018 of $86.64.

SEC source: 0001209191-18-015302 · doc4.xml · nonDerivative · entry 4

Hienrich Edi · CIK 0001472187 · SVP/Managing Director EMEA

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,864

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · kind: The reporting person received 5,392 shares of common stock upon the net exercise of 24,590 SARs. The reporting person forfeited 12,713 shares of common stock underlying the SARs in payment of the exercise price and 6,485 shares of common stock underlying the SARs to satisfy the withholding tax obligations resulting from the exercise, using the closing stock price on February 27, 2018 of $86.64.

SEC source: 0001209191-18-015302 · doc4.xml · nonDerivative · entry 3

Hienrich Edi · CIK 0001472187 · SVP/Managing Director EMEA

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,274

F1 · kind: The reporting person received 2,840 shares of common stock upon the net exercise of 16,250 stock appreciation rights ("SARs"). The reporting person forfeited 9,995 shares of common stock underlying the SARs in payment of the exercise price and 3,415 shares of common stock underlying the SARs to satisfy the withholding tax obligations resulting from the exercise, using the closing stock price on February 27, 2018 of $86.64.

SEC source: 0001209191-18-015302 · doc4.xml · nonDerivative · entry 2

Hienrich Edi · CIK 0001472187 · SVP/Managing Director EMEA

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,689

F1 · kind: The reporting person received 2,840 shares of common stock upon the net exercise of 16,250 stock appreciation rights ("SARs"). The reporting person forfeited 9,995 shares of common stock underlying the SARs in payment of the exercise price and 3,415 shares of common stock underlying the SARs to satisfy the withholding tax obligations resulting from the exercise, using the closing stock price on February 27, 2018 of $86.64.

SEC source: 0001209191-18-015302 · doc4.xml · nonDerivative · entry 1

Hienrich Edi · CIK 0001472187 · SVP/Managing Director EMEA

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,684

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reporting person received 2,840 shares of common stock upon the net exercise of 16,250 stock appreciation rights ("SARs"). The reporting person forfeited 9,995 shares of common stock underlying the SARs in payment of the exercise price and 3,415 shares of common stock underlying the SARs to satisfy the withholding tax obligations resulting from the exercise, using the closing stock price on February 27, 2018 of $86.64.

SEC source: 0001209191-18-013702 · doc4.xml · nonDerivative · entry 2

Hienrich Edi · CIK 0001472187 · SVP/Managing Director EMEA

10b5-1 filing: Not disclosed

Ownership: Indirect · By Wife

Disclosed balance after: 1,390

F1 · kind: Consists of restricted stock units ("RSU") under the Herbalife Ltd. 2014 Stock Incentive Plan. Each RSU represents a contingent right to receive one share of Herbalife Ltd. common stock on vesting. This award will vest 20% each on February 26, 2019 and February 26, 2020, and 60% on February 26, 2021.

SEC source: 0001209191-18-013702 · doc4.xml · nonDerivative · entry 1

Hienrich Edi · CIK 0001472187 · SVP/Managing Director EMEA

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,793

F1 · kind: Consists of restricted stock units ("RSU") under the Herbalife Ltd. 2014 Stock Incentive Plan. Each RSU represents a contingent right to receive one share of Herbalife Ltd. common stock on vesting. This award will vest 20% each on February 26, 2019 and February 26, 2020, and 60% on February 26, 2021.

SEC source: 0001209191-18-014707 · doc4.xml · derivative · entry 5

Hienrich Edi · CIK 0001472187 · SVP/Managing Director EMEA

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 19,832 shares

Expires 2020-05-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reporting person received 6,611 shares of common stock upon the net exercise of 19,832 stock appreciation rights ("SARS"). The reporting person forfeited 5,272 shares of common stock underlying the SARS in payment of the exercise price and 7,949 shares of common stock underlying the SARS to satisfy the withholding tax obligations resulting from the exercise, using the closing stock price on February 26, 2018 of $86.30.

SEC source: 0001209191-18-014707 · doc4.xml · nonDerivative · entry 3

Hienrich Edi · CIK 0001472187 · SVP/Managing Director EMEA

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,434

F1 · kind: The reporting person received 6,611 shares of common stock upon the net exercise of 19,832 stock appreciation rights ("SARS"). The reporting person forfeited 5,272 shares of common stock underlying the SARS in payment of the exercise price and 7,949 shares of common stock underlying the SARS to satisfy the withholding tax obligations resulting from the exercise, using the closing stock price on February 26, 2018 of $86.30.

SEC source: 0001209191-18-014707 · doc4.xml · nonDerivative · entry 2

Hienrich Edi · CIK 0001472187 · SVP/Managing Director EMEA

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,383

F1 · kind: The reporting person received 6,611 shares of common stock upon the net exercise of 19,832 stock appreciation rights ("SARS"). The reporting person forfeited 5,272 shares of common stock underlying the SARS in payment of the exercise price and 7,949 shares of common stock underlying the SARS to satisfy the withholding tax obligations resulting from the exercise, using the closing stock price on February 26, 2018 of $86.30.

SEC source: 0001209191-18-014707 · doc4.xml · nonDerivative · entry 1

Hienrich Edi · CIK 0001472187 · SVP/Managing Director EMEA

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,625

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reporting person received 6,611 shares of common stock upon the net exercise of 19,832 stock appreciation rights ("SARS"). The reporting person forfeited 5,272 shares of common stock underlying the SARS in payment of the exercise price and 7,949 shares of common stock underlying the SARS to satisfy the withholding tax obligations resulting from the exercise, using the closing stock price on February 26, 2018 of $86.30.

SEC source: 0001209191-18-013702 · doc4.xml · derivative · entry 6

Hienrich Edi · CIK 0001472187 · SVP/Managing Director EMEA

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,531

Underlying: Common Stock · 3,531 shares

Expires 2027-02-27

F5 · kind: On February 27, 2017, the reporting person was granted an award of 17,655 SARs. The amount and timing of the vesting of these SARs is dependent upon the achievement by the Company of certain performance criteria for each of fiscal 2017, 2018 and 2019. The performance criteria for 2017 was met, resulting in 3,531 SARs which will vest on February 27, 2018.

SEC source: 0001209191-18-013702 · doc4.xml · derivative · entry 5

Hienrich Edi · CIK 0001472187 · SVP/Managing Director EMEA

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,718

Underlying: Common Stock · 3,359 shares

Expires 2026-05-09

F4 · kind: On May 9, 2016, the reporting person was granted an award of 16,795 SARs. The amount and timing of the vesting of these SARs is dependent upon the achievement by the Company of certain performance criteria for each of fiscal 2016, 2017 and 2018. The performance criteria for 2017 was met, resulting in 3,359 SARs which will vest on May 9, 2018.

SEC source: 0001209191-18-013702 · doc4.xml · derivative · entry 4

Hienrich Edi · CIK 0001472187 · SVP/Managing Director EMEA

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,500

Underlying: Common Stock · 7,500 shares

Expires 2025-05-07

F3 · kind: On May 7, 2015, the reporting person was granted an award of 12,500 SARs. The amount and timing of the vesting of these SARs is dependent upon the achievement by the Company of certain performance criteria for each of fiscal 2016, 2017 and 2018. The performance criteria for 2017 was met, resulting in 7,500 SARs which will vest on May 7, 2018.

SEC source: 0001209191-18-013702 · doc4.xml · derivative · entry 3

Hienrich Edi · CIK 0001472187 · SVP/Managing Director EMEA

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,626

Underlying: Common Stock · 19,576 shares

Expires 2025-03-02

F2 · kind: On March 2, 2015, the reporting person was granted an award of 32,626 stock appreciation rights ("SARs"). The amount and timing of the vesting of these SARs is dependent upon the achievement by Herbalife Ltd. (the "Company") of certain performance criteria for each of fiscal 2015, 2016 and 2017. The performance criteria for 2017 was met, resulting in 19,576 SARs which will vest on March 2, 2018.

SEC source: 0001209191-17-031676 · doc4.xml · nonDerivative · entry 5

Hienrich Edi · CIK 0001472187 · SVP/Managing Director EMEA

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 8, 2016.

F4 · price: This transaction was executed in multiple trades at prices ranging from $71.31 to $72.27. The price reported above reflects the average sale price of $72.27. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001209191-17-031676 · doc4.xml · derivative · entry 6

Hienrich Edi · CIK 0001472187 · SVP/Managing Director EMEA

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 24,000 shares

Expires 2019-08-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 8, 2016.

SEC source: 0001209191-17-031676 · doc4.xml · nonDerivative · entry 4

Hienrich Edi · CIK 0001472187 · SVP/Managing Director EMEA

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,631

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 8, 2016.

SEC source: 0001209191-17-031676 · doc4.xml · nonDerivative · entry 3

Hienrich Edi · CIK 0001472187 · SVP/Managing Director EMEA

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,119

F3 · kind: The reporting person received 8,631 shares of common stock upon the net exercise of the 24,000 stock appreciation rights ("SARS"). The reporting person forfeited 4,991 shares of common stock underlying the SARS in payment of the exercise price and 10,378 shares of common stock underlying the SARS to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on May 9, 2017 of $72.81.

SEC source: 0001209191-17-031676 · doc4.xml · nonDerivative · entry 2

Hienrich Edi · CIK 0001472187 · SVP/Managing Director EMEA

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,497

F3 · kind: The reporting person received 8,631 shares of common stock upon the net exercise of the 24,000 stock appreciation rights ("SARS"). The reporting person forfeited 4,991 shares of common stock underlying the SARS in payment of the exercise price and 10,378 shares of common stock underlying the SARS to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on May 9, 2017 of $72.81.

SEC source: 0001209191-17-031676 · doc4.xml · nonDerivative · entry 1

Hienrich Edi · CIK 0001472187 · SVP/Managing Director EMEA

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,488

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 8, 2016.

F2 · balance_after: The total number of shares has been adjusted to include 4,628 shares inadvertently omitted from prior reports.

SEC source: 0001209191-17-015000 · doc4.xml · derivative · entry 4

Hienrich Edi · CIK 0001472187 · SVP/Managing Director EMEA

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,359

Underlying: Common Stock · 3,359 shares

Expires 2026-05-09

F4 · balance_after: On May 9, 2016, the reporting person was granted an award of 16,795 SARs. The amount and timing of the vesting of these SARs is dependent upon the achievement by the Company of certain performance criteria for each of fiscal 2016, 2017 and 2018. The performance criteria for 2016 was met, resulting in 3,359 SARs which will vest on May 9, 2017.

SEC source: 0001209191-17-015000 · doc4.xml · derivative · entry 3

Hienrich Edi · CIK 0001472187 · SVP/Managing Director EMEA

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Common Stock · 2,500 shares

Expires 2025-05-07

F3 · balance_after: On May 7, 2015, the reporting person was granted an award of 12,500 SARs. The amount and timing of the vesting of these SARs is dependent upon the achievement by the Company of certain performance criteria for each of fiscal 2015, 2016 and 2017. The performance criteria for 2016 was met, resulting in 2,500 SARs which will vest on May 7, 2017.

SEC source: 0001209191-17-015000 · doc4.xml · derivative · entry 2

Hienrich Edi · CIK 0001472187 · SVP/Managing Director EMEA

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,050

Underlying: Common Stock · 6,525 shares

Expires 2025-03-02

F2 · balance_after: On March 2, 2015, the reporting person was granted an award of 32,626 SARs. The amount and timing of the vesting of these SARs is dependent upon the achievement by the Company of certain performance criteria for each of fiscal 2015, 2016 and 2017. The performance criteria for 2016 was met, resulting in 6,525 SARs which will vest on March 2, 2017.

SEC source: 0001209191-17-015000 · doc4.xml · derivative · entry 1

Hienrich Edi · CIK 0001472187 · SVP/Managing Director EMEA

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,245

Underlying: Common Stock · 11,547 shares

Expires 2024-04-30

F1 · balance_after: On April 30, 2014, the reporting person was granted an award of 19,245 stock appreciation rights ("SARs"). The amount and timing of the vesting of these SARs is dependent upon the achievement by Herbalife Ltd. (the "Company") of certain performance criteria for each of fiscal 2014, 2015 and 2016. The performance criteria for 2016 was met, resulting in 11,547 SARs which will vest on April 30, 2017.

SEC source: 0001209191-16-157077 · doc4.xml · derivative · entry 1

Hienrich Edi · CIK 0001472187 · SVP/Managing Director EMEA

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,133

Underlying: Common Stock · 9,079 shares

Expires 2023-12-19

F1 · derivative.exercise_date: On December 19, 2013, the reporting person was granted an award of 15,133 stock appreciation rights (SARs). The amount and timing of the vesting of these SARs were dependent upon Herbalife Ltd.'s achievement of certain performance criteria for each of fiscal 2013, 2014 and 2015. The performance criteria were met in 2015, resulting in the vesting of 9,079 SARs subject to this award on June 21, 2016.

F1 · balance_after: On December 19, 2013, the reporting person was granted an award of 15,133 stock appreciation rights (SARs). The amount and timing of the vesting of these SARs were dependent upon Herbalife Ltd.'s achievement of certain performance criteria for each of fiscal 2013, 2014 and 2015. The performance criteria were met in 2015, resulting in the vesting of 9,079 SARs subject to this award on June 21, 2016.